UK markets closed

Guangdong Taiantang Pharmaceutical Co., Ltd. (002433.SZ)

Shenzhen - Shenzhen Delayed price. Currency in CNY
Add to watchlist
0.2100-0.3000 (-58.82%)
At close: 03:04PM CST
Currency in CNY

Valuation measures4

Market cap (intra-day) 161.02M
Enterprise value 1.32B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.48
Price/book (mrq)0.42
Enterprise value/revenue 3.88
Enterprise value/EBITDA -2.44

Trading information

Stock price history

Beta (5Y monthly) 0.01
52-week change 3-89.34%
S&P500 52-week change 323.76%
52-week high 33.3500
52-week low 30.1900
50-day moving average 30.5870
200-day moving average 32.0217

Share statistics

Avg vol (3-month) 37.56M
Avg vol (10-day) 313.88M
Shares outstanding 5766.77M
Implied shares outstanding 6809.37M
Float 8618.95M
% held by insiders 124.89%
% held by institutions 10.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 40.30
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 417 Jul 2020
Last split factor 220:10
Last split date 322 Apr 2014

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)-38.60%

Management effectiveness

Return on assets (ttm)-21.05%
Return on equity (ttm)-114.26%

Income statement

Revenue (ttm)339.65M
Revenue per share (ttm)0.44
Quarterly revenue growth (yoy)-50.80%
Gross profit (ttm)N/A
EBITDA -1.54B
Net income avi to common (ttm)-2.2B
Diluted EPS (ttm)-2.8700
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)93.59M
Total cash per share (mrq)0.12
Total debt (mrq)855.13M
Total debt/equity (mrq)251.12%
Current ratio (mrq)0.49
Book value per share (mrq)0.50

Cash flow statement

Operating cash flow (ttm)-11.46M
Levered free cash flow (ttm)1.96B